These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 10161584

  • 21. The effect of a closed formulary on prescription drug use and costs.
    Motheral BR, Henderson R.
    Inquiry; ; 36(4):481-91. PubMed ID: 10711322
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Pharmaceutical formularies: the right formula for cost and utilization?
    Austin B.
    Find Brief; 2004 Aug; 7(5):1-3. PubMed ID: 15298009
    [No Abstract] [Full Text] [Related]

  • 25. Are incentive-based formularies inversely associated with drug utilization in managed care?
    Gleason PP, Gunderson BW, Gericke KR.
    Ann Pharmacother; 2005 Feb; 39(2):339-45. PubMed ID: 15644478
    [Abstract] [Full Text] [Related]

  • 26. Use of health-related quality of life information in managed care formulary decision-making.
    Wu WK, Sause RB, Zacker C.
    Res Social Adm Pharm; 2005 Dec; 1(4):579-98. PubMed ID: 17138497
    [Abstract] [Full Text] [Related]

  • 27. Expanding formulary and drug-use review programs.
    Cheung MO.
    J Health Care Benefits; 1993 Dec; 3(1):33-6. PubMed ID: 10130346
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The arrival of consumer-centric healthcare.
    Gupta AK.
    Manag Care Q; 2003 Dec; 11(1):20-3. PubMed ID: 12790062
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The impact of managed care on pharmacy practice.
    Schafermeyer KW.
    Pharm Pract Manag Q; 2000 Jan; 19(4):99-116. PubMed ID: 10787569
    [Abstract] [Full Text] [Related]

  • 32. Dialogue. Prescription for problems? Capitating mental health drugs--the great debate.
    Docherty JP, Browne RA, Farmer M.
    Behav Healthc Tomorrow; 1998 Oct; 7(5):32-8. PubMed ID: 10185199
    [Abstract] [Full Text] [Related]

  • 33. Control of prescription costs--is it possible?
    Renaud PN.
    Empl Benefits J; 2002 Mar; 27(1):11-4. PubMed ID: 11859536
    [Abstract] [Full Text] [Related]

  • 34. How hospitals can use internal benchmark data to create effective managed care arrangements.
    Alba T, Souders J, McGhee G.
    Manag Care Q; 1994 Mar; 2(2):79-89. PubMed ID: 10134007
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Managed care risk contracts and substance abuse treatment.
    Sturm R.
    Inquiry; 2000 Mar; 37(2):219-25. PubMed ID: 10985114
    [Abstract] [Full Text] [Related]

  • 38. Reducing patient drug acquisition costs can lower diabetes health claims.
    Mahoney JJ.
    Am J Manag Care; 2005 Aug; 11(5 Suppl):S170-6. PubMed ID: 16111439
    [Abstract] [Full Text] [Related]

  • 39. Special report. Integrating managed care. When managed care is a system.
    Humbert V.
    Bus Health; 1991 Aug; [integrating]():20-30. PubMed ID: 10113632
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.